Epstein Secrets

e Nuevo Mexico prison gang, pleaded guilty Sept. 25 to a racketeer influenced and corrupt organization (RICO) indictment." The indictment, "to which Gomez pleaded guilty, details various acts and communications since 2002 in which Gomez participated in relation to his membership in the organization. As

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

n Gang Member Pleads Guilty To Racketeering. The J oc Alamos (NM) Daily Pact (9/30, Clark) reports from Albuquerque, New Mexico, "Jonathan 'Baby G' Gomez, a member of the Syndicato de Nuevo Mexico prison gang, pleaded guilty Sept. 25 to a racketeer influenced and corrupt organization (RICO) indictment

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Nuevo Mexico prison gang, pleaded guilty Sept. 25 to a racketeer influenced and corrupt organization (RICO) indictment." The indictment, "to which Gomez pleaded guilty, details various acts and communications since 2002 in which Gomez participated in relation to his membership in the organization. As

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

rison gang, pleaded guilty Sept. 25 to a racketeer influenced and corrupt organization (RICO) indictment." The EFTA01658512 indictment, "to which Gomez pleaded guilty, details various acts and communications since 2002 in which Gomez participated in relation to his membership in the organization. As

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human